Targeted Clinical Trial Design/Rediscovering Biomarkers

1 post / 0 new
CButterfly's picture
Targeted Clinical Trial Design/Rediscovering Biomarkers

Targeted Designs for Clinical Trials - July 19 & 20, 2007 in Philadelphia, PA

Learn from industry leading experts as they discuss strategies to accelerate drug development, lower trial costs and reduce development risks. Allen D. Roses, Senior Vice President of Pharmacogenetics for GlaxoSmithKline delivers the keynote address on New Opportunities to Bring Drugs and Pharmacogenetics into the Clinic.

Discussions Include:
* Using Proof of Concept (PoC) Trials to spot dead-ends in drug development
* Improving the rate of success at Phase III using adaptive clinical trials
* Accelerating drug development by using combination Phase II/III trials
* Early stopping rules for clinical trials
* Using PK/PD modeling in rational drug development
* Overcoming challenges to bringing predictive test results into the clinic
* The role of biomarkers in drug development
* Imaging in targeted clinical trial designs
* Rationale and Approaches for Phase IV Studies

Clinical Trials Agenda
Rediscovering Biomarkers: Detection, Development, and Validation - July 23 & 24, 2007 in La Jolla, CA

GTCbios Rediscovering Biomarkers conference provides comprehensive coverage of a wide range of topics including:

o Biomarker Application in Oncology Clinical Development
o Drug Discovery, Development and Diagnostics of Biomarkers
o Tools for Improving Measurement, Safety and Validation of Biomarkers
o Upcoming Technology and Trends

Biomarkers Agenda